Kimberly-Clark Corporation's (KMB) shares have dropped by 20%, but some perceive this slide as an opportunity to acquire shares of this
Dividend Aristocrat at a more engaging price. The consumer products company intends to acquire
Kenvue, marking a significant shift in the healthcare and wellness market. Despite various investors — including Commonwealth Equity Services and Asset Management One Co. — lowering their positions in KMB,
TD Cowen upholds its rating for the company, although it has decreased its price target. KMB's quarterly dividends persist, and stock analysts like
Jim Cramer praise the company's management and future prospects. The big topic, however, is KMB's purchase of Kenvue, which will boost its global standing despite coming with potential risks. Moreover, the company continues to make strides in its Powering Care Transformation, showcasing a significant commitment to innovation and growth.
Kimberly-Clark Corp KMB News Analytics from Mon, 21 Apr 2025 07:00:00 GMT to Sat, 10 Jan 2026 02:40:50 GMT -
Rating -2
- Innovation 3
- Information 8
- Rumor 6
